We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases

    Purpose

    Chemotherapy-naive patients with unresectable colorectal liver metastases (CRLM) have been the best responders to hepatic arterial infusion...

    Floris S. Verheij, Koert F. D. Kuhlmann, ... Michael I. D’Angelica in Annals of Surgical Oncology
    Article 28 August 2023
  2. The oligometastatic spectrum in the era of improved detection and modern systemic therapy

    Metastases remain the leading cause of cancer-related mortality. The oligometastasis hypothesis postulates that a spectrum of metastatic spread...

    Rohan R. Katipally, Sean P. Pitroda, ... Ralph R. Weichselbaum in Nature Reviews Clinical Oncology
    Article 12 July 2022
  3. Survival outcomes of lung metastases from colorectal cancer treated with pulmonary metastasectomy or modern systemic chemotherapy: a single institution experience

    Background

    Although pulmonary metastasectomy is an accepted treatment strategy for resectable lung metastases (LM) from colorectal cancer (CRC), its...

    Yutaka Shishido, Masayuki Ishii, ... Hiroshi Higashiyama in Journal of Cardiothoracic Surgery
    Article Open access 14 November 2023
  4. Current treatment of systemic lupus erythematosus: a clinician's perspective

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Its variable course makes it difficult to standardize patient treatment. This...

    Pawlak-Buś Katarzyna, Schmidt Wiktor, ... Leszczyński Piotr in Rheumatology International
    Article Open access 12 May 2023
  5. The neurovascular unit and systemic biology in stroke — implications for translation and treatment

    Ischaemic stroke is a leading cause of disability and death for which no acute treatments exist beyond recanalization. The development of novel...

    Steffen Tiedt, Alastair M. Buchan, ... Eng H. Lo in Nature Reviews Neurology
    Article 09 September 2022
  6. Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey

    Biological agents are widely used for the management of systemic rheumatic diseases (SRDs) and their therapeutic implications have been expanded...

    Christos Ermeidis, Theodoros Dimitroulas, ... Dimitrios Kouvelas in Rheumatology International
    Article 14 February 2023
  7. Metabolomics in systemic sclerosis

    Systemic sclerosis is a rare autoimmune condition leading to incurable complications. Therefore fast and precise diagnosis is crucial to prevent...

    Zuzanna Gogulska, Zaneta Smolenska, ... Michał Chmielewski in Rheumatology International
    Article Open access 09 July 2024
  8. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?

    Objectives

    Response assessment to neoadjuvant systemic treatment (NAST) to guide individualized treatment in breast cancer is a clinical research...

    Lie Cai, Chris Sidey-Gibbons, ... Michael Golatta in European Radiology
    Article Open access 14 September 2023
  9. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma

    Background

    Metastasectomy for selected patients with melanoma was associated with improved survival in the era before effective systemic therapy....

    Andrew T. Li, Kavita Vakharia, ... Sydney Ch’ng in Annals of Surgical Oncology
    Article 04 August 2021
  10. Modern view on the diagnostics and treatment of adenomyosis

    Adenomyosis is identified by the enlargement of the uterus secondary to such areas of the endometrium as the endometrial glands and stroma located...

    Rymgul S. Moldassarina in Archives of Gynecology and Obstetrics
    Article 15 April 2023
  11. Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies

    Purpose of Review

    Modern advances in cancer treatment with immunotherapy have created substantial hope for patients and oncologists alike due to a new...

    Amy An, David Hui in Current Oncology Reports
    Article 03 February 2022
  12. Neuro-ophthalmic complications of modern anti-cancer drugs

    Purpose

    Targeted cancer therapies have been responsible for a dramatic shift in treatment strategies for cancer, and the number of drugs, classes, and...

    Joshua A. Oskam, Helen V. Danesh-Meyer in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article Open access 12 February 2024
  13. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma

    The field of kidney cancer has dramatically evolved over the past several years due to notable advances. Most importantly, systemic treatment options...
    Rana R. McKay, Eric A. Singer
    Book 2023
  14. Brain metastases: new systemic treatment approaches

    Background

    Brain metastases (BM) still present a clinical challenge in oncology. Treatment of BM was mainly based on local approaches including...

    Ariane Steindl, Anna Sophie Berghoff in memo - Magazine of European Medical Oncology
    Article Open access 22 May 2021
  15. The Development of Modern Radiation Therapy

    Purpose of Review

    Radiation therapy is a treatment modality used in the management of patients with cancer that utilizes ionizing radiation to kill...

    Kaitlyn Lapen, Yoshiya Yamada in Current Physical Medicine and Rehabilitation Reports
    Article 29 April 2023
  16. Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials

    Purpose

    Hand-foot syndrome (HFS) and hand-foot skin reaction (HFSR) are common toxicities of several systemic cancer treatments. Multikinase...

    Jessa Gilda P. Pandy, Paula Isabel G. Franco, Rubi K. Li in Supportive Care in Cancer
    Article 02 June 2022
  17. Avapritinib in the Treatment of Systemic Mastocytosis: an Update

    Purpose of Review

    Patients with systemic mastocytosis, a dangerous and rare myeloid neoplasm, have long had few therapies available to them and,...

    Samantha Below, Laura C. Michaelis in Current Hematologic Malignancy Reports
    Article 27 September 2021
  18. Precision medicine in systemic lupus erythematosus

    Systemic lupus erythematosus (SLE) is an autoimmune disease that has diverse clinical manifestations, ranging from restricted cutaneous involvement...

    Serena Fasano, Alessandra Milone, ... Francesco Ciccia in Nature Reviews Rheumatology
    Article 11 April 2023
  19. The therapeutic potential of immunoengineering for systemic autoimmunity

    Disease-modifying drugs have transformed the treatment options for many systemic autoimmune diseases. However, an evolving understanding of disease...

    David A. McBride, Ryan M. Jones, ... Nisarg J. Shah in Nature Reviews Rheumatology
    Article 21 February 2024
Did you find what you were looking for? Share feedback.